Publicaciones en colaboración con investigadores/as de John Radcliffe Hospital (13)

2022

  1. Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery

    BJS Open, Vol. 6, Núm. 1

2021

  1. Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic

    Colorectal Disease, Vol. 23, Núm. 3, pp. 732-749

2020

  1. Glutamine Links Obesity to Inflammation in Human White Adipose Tissue

    Cell Metabolism, Vol. 31, Núm. 2, pp. 375-390.e11

2018

  1. Erratum to: The Intensive Care Global Study on Severe Acute Respiratory Infection (IC‑GLOSSARI): a multicenter, multinational, 14-day inception cohort study (Intensive Care Medicine, (2016), 42, 5, (953), 10.1007/s00134-016-4317-4)

    Intensive Care Medicine

2013

  1. Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression

    British Journal of Haematology, Vol. 163, Núm. 2, pp. 235-239

  2. Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34+ progenitor cells

    British Journal of Haematology, Vol. 160, Núm. 6, pp. 842-850

  3. Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes

    Haematologica, Vol. 98, Núm. 12, pp. 1856-1864

2012

  1. European bilateral pediatric cochlear implant forum consensus statement

    Otology and Neurotology, Vol. 33, Núm. 4, pp. 561-565

  2. Mortality after surgery in Europe: A 7 day cohort study

    The Lancet, Vol. 380, Núm. 9847, pp. 1059-1065

  3. Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics

    PLoS ONE, Vol. 7, Núm. 8

  4. TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia

    PLoS ONE, Vol. 7, Núm. 2

2010

  1. Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia

    Leukemia

2003

  1. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow

    Blood, Vol. 102, Núm. 8, pp. 3043-3051